RN7SL791P

Across TCGA pan-cancer cohorts, RN7SL791P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL791P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RN7SL791P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL791P expression acts as an unfavorable survival marker, although some lineages such as LGG and STAD show a favorable association.

THCA, KIRC, and KICH are the cancer types where RN7SL791P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.889	0.977	<.001	114	view →
KIRC	DFS	Tertile	All	0.352	0.653	<.001	108	view →
KICH	DFS	Tertile	All	0.035	0.904	<.001	90	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	81	view →
SKCM	DFS	Tertile	All	0.046	0.757	<.001	36	view →
OV	DFS	Tertile	IV	0.197	0.484	.002	30	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	18	view →
LGG	OS	Tertile	All	0.817	0.421	.018	9	view →
STAD	DFS	Tertile	IV	0.616	0.171	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL791P–THCA (OS)

Open the THCA breakdown →